Pfizer to request COVID-19 vaccine full approval in ‘first half of 2021’
January 19 2021, 08:00
Pfizer and BioNTech plan to seek full regulatory approval for their coronavirus vaccine in the first half of the year.
Pfizer and BioNTech plan to seek full regulatory approval for their coronavirus vaccine in the first half of the year.
Source:
FOX News